GGrantIndex
Sort

85,873 grants matching alzheimers

Clinical Core

$904,645
Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru · P30 · FY2023 · AG

Antipsychotic Discontinuation in Alzheimer s Disease

$904,527
New York State Psychiatric Institute · R01 · FY2005 · AG

Clinical Core

$904,344
Douglas R Galasko · University Of California, San Diego · P50 · FY2015 · AG

Implantable Microarray Probe for Real-Time Glutamate and GABA Detection

$903,957
Nicolaie Andrei Moldovan · Alcorix · R42 · FY2023 · NS

Core B - Data Management, Harmonization, and Data Transfer Core

$903,819
Li-San Wang · University Of Pennsylvania · U54 · FY2017 · AG

High throughput tau oligomer drug screening assay for Alzheimer's disease

$903,675
James G. Moe · Oligomerix, Inc · R44 · FY2013 · AG

Design, Development, and Validation of an AI-enabled Legal Planning and Financial Management Training Solution for ADRD Caregivers

$903,624
Christian Elliott · Whiplash Technology, Inc. · R44 · FY2022 · AG

Measuring cellular senescence to predict and prevent peripheral neuropathy

$903,506
Natalia Mitin · Sapere Bio, Inc. · R44 · FY2022 · AG

Adaptive Testing of Cognitive Function based on multi-dimensionalItem Response Theory

$903,302
Robert D Gibbons · University Of Chicago · R56 · FY2023 · AG

Low-cost detection of dementia using electronic health records data: validation and testing of the eRADAR algorithm in a pragmatic, patient-centered trial.

$903,251
Sascha Dublin · Kaiser Foundation Research Institute · R01 · FY2021 · AG

Role of clonal somatic mutations in microglia and Alzheimer’s disease

$903,172
Yue Huang · Boston Children'S Hospital · R01 · FY2024 · AG

CAREER: Structural biology in cellular environments using high-sensitivity NMR

$903,167
Kendra K Frederick · University Of Texas Southwestern Medical Center · · FY2018 · BIO

Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids

$903,048
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2025 · DA

Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids

$903,048
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2024 · DA

Core B: Clinical Core

$902,942
Douglas R Galasko · University Of California, San Diego · P30 · FY2025 · AG

Pathogenesis Informs Therapy for Glycosphingolipid and Glycoprotein Disorders

$902,914
Cynthia Tifft · National Human Genome Research Institute · ZIA · FY2025 · HG

Implantable Microarray Probe for Real-Time Glutamate and GABA Detection

$902,911
Nicolaie Andrei Moldovan · Alcorix · R42 · FY2024 · NS

Viral Strategies for Functional Connectomics in the Visual System

$902,821
R Clay Reid · Allen Institute · R01 · FY2020 · NS

Viral Strategies for Functional Connectomics in the Visual System

$902,821
R Clay Reid · Allen Institute · R01 · FY2019 · NS

Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors

$902,779
D. Martin Watterson · Northwestern University At Chicago · U01 · FY2013 · AG

CENTER FOR COMPUTATIONAL BIOLOGY: BIOLOGICAL PROJECTS

$902,750
University Of California Los Angeles · U54 · FY2004 · RR

Enhancing Quality of Life for Older Adults With and Without MCI through Social Engagement Over Video Technology

$902,580
Dillon Myers · Potluck, Llc · R44 · FY2020 · AG

Development of STEP Allosteric Inhibitors as Novel Therapeutics for Alzheimer's Disease

$902,529
Lutz Tautz · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AG

ALZHEIMERS RESEARCH PROJECT: Alzheimer's disease drug development

$902,370
Nigel H. Greig · National Institute On Aging · ZIA · FY2024 · AG

Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention

$902,320
John V Hobday · Healthcare Interactive, Inc. · R44 · FY2014 · AG